Loma Linda University

TheScholarsRepository@LLU: Digital Archive of Research,
Scholarship & Creative Works
Loma Linda University Electronic Theses, Dissertations & Projects

3-2018

Evaluating Cognitive Changes in Patients
Receiving Outpatient Alcohol Treatment
Michelle McDonnell

Follow this and additional works at: http://scholarsrepository.llu.edu/etd
Part of the Clinical Psychology Commons, and the Medicine and Health Sciences Commons
Recommended Citation
McDonnell, Michelle, "Evaluating Cognitive Changes in Patients Receiving Outpatient Alcohol Treatment" (2018). Loma Linda
University Electronic Theses, Dissertations & Projects. 507.
http://scholarsrepository.llu.edu/etd/507

This Dissertation is brought to you for free and open access by TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative
Works. It has been accepted for inclusion in Loma Linda University Electronic Theses, Dissertations & Projects by an authorized administrator of
TheScholarsRepository@LLU: Digital Archive of Research, Scholarship & Creative Works. For more information, please contact
scholarsrepository@llu.edu.

LOMA LINDA UNIVERSITY
School of Behavioral Health
in conjunction with the
Faculty of Graduate Studies

____________________

Evaluating Cognitive Changes in Patients Receiving Outpatient Alcohol Treatment

by

Michelle McDonnell

____________________

A Dissertation submitted in partial satisfaction of
the requirements for the degree
Doctor of Philosophy in Clinical Psychology

____________________

March 2018

© 2018
Michelle McDonnell
All Rights Reserved

Each person whose signature appears below certifies that this dissertation in his/her
opinion is adequate, in scope and quality, as a dissertation for the degree Doctor of
Philosophy.

, Chairperson
Grace J. Lee, Assistant Professor of Psychology

Holly E. R. Morrell, Associate Professor of Psychology

Suranee Waleszonia, Licensed Clinical Psychologist, Fullerton Neuropsychological
Service

Ricardo Whyte, Assistant Professor of Medicine

iii

ACKNOWLEDGEMENTS

I would like to express my deepest gratitude to Dr. Grace Lee, without whom I
would not have been able to tackle this project. Thank you for your guidance, support,
and endless words of encouragement. You have been a wealth of information, and truly
an inspiration as I have transitioned through the graduate program. Many of the
unparalleled opportunities provided to me, beyond this document, would not have been
possible without your guidance or dedication to my professional development.
Dr. Suranee Walezsonia, I am eternally grateful for your willingness to recruit me
for the initial period of data collection for this study. You provided the ground work for
what blossomed into this study. I am also so thankful for your continued encouragement
and presence across multiple aspects of my training.
I would also like to thank Dr. Ricardo Whyte for his advice and direction for this
project. I appreciate your countless hours of dedication and constant availability making
this difficult task much more manageable.
Dr. Holly Morrell, I much appreciate your unwavering attention to detail, mastery
of statistics, and seamless ability to instruct your students. Furthermore, I am thankful for
your willingness to take on this project and convey your incomparable knowledge of
statistics and addiction research.
To my parents and Brad, your love and support through this endeavor has been
immensely encouraging, and at times, was the only fuel for my fire to continue with this
grueling process. Brad, you have dedicated more than time or money into my education,
but confidence, hopefulness, and comfort, which mean more than words can express to
me.

iv

CONTENT

Approval Page .................................................................................................................... iii
Acknowledgements ............................................................................................................ iv
List of Tables ..................................................................................................................... vi
List of Abbreviations ........................................................................................................ vii
Abstract ............................................................................................................................ viii
Chapter
1. Introduction ..............................................................................................................1
Physical Health Risks of Alcohol Use ...............................................................2
Neurological Effects of Chronic Alcohol Use ...................................................4
Neuropsychological Effect of Chronic Alcohol Use .........................................6
Visuospatial Functioning .............................................................................6
Learning and Memory..................................................................................7
Executive Functioning .................................................................................7
Language, Attention, and Processing Speed ................................................8
Recovery of Function after Abstinence .............................................................9
Factors Related to Treatment Outcome ...........................................................13
Impact of Relapse on Health and Recovery.....................................................14
Aims and Hypotheses ......................................................................................15
2. Method ...................................................................................................................17
Participants .......................................................................................................17
Procedures ........................................................................................................17
Measures ..........................................................................................................18
Analyses ...........................................................................................................19
3. Results ....................................................................................................................21
4. Discussion ..............................................................................................................33
References ..........................................................................................................................38

v

TABLES

Tables

Page

1. Pearson Correlations Between Demographics and Cognitive Variables at
the Start and End of Treatment ..............................................................................22
2. Chi-Square and Independent Samples t-test Evaluating Group Differences
(Treatment Completion vs. Non-Completion) in Demographic Variables ............22
3. Independent Samples t-test Evaluating Differences in Demographic and
RBANS Baseline Variables for Within Treatment Completers (Second
Testing vs. Non-Second Testing) ..........................................................................23
4. Repeated Measures Analysis of Covariance Evaluating Effect of Intensive
Outpatient Treatment on Cognitive Functioning, Controlling for Gender,
Education, and Ethnicity ........................................................................................26
5. Independent Samples t-Test Comparing Cognitive Performance in
Cognitive Domains among Those Who Did and Did Not Complete
Treatment ..............................................................................................................27
6. Independent Samples t-Test Comparing Performances in Individual
Subtests among Those Who Did and Did Not Complete Treatment .....................28
7. Results of Binary Logistic Regression Predicting Treatment Completion
from Performance on Individual Subtests and Overall Indices .............................29
8. Analysis of Covariance (ANCOVA) Testing Mean Differences in Baseline
Cognitive Functioning Between Individuals Who Did and Did Not Attend
Previous Alcohol Treatment, Controlling for Ethnicity, Education, and
Gender. ...................................................................................................................31
9. Results of ANCOVAs Testing Mean Differences in Post-treatment
Cognitive Functioning between Individuals who Did and Did Not Attend
Previous Alcohol Treatment, Controlling for Ethnicity, Education, and
Gender ....................................................................................................................32

vi

ABBREVIATIONS

DSM-5

Diagnostic and Statistical Manual of Mental DisordersFifth Edition

NIAAA

National Institute on Alcohol Abuse and Alcoholism

AUD

Alcohol Use Disorder

fMRI

functional Magnetic Resonance Imaging

KS

Korakoff’s Syndrome

CBM

Cognitive Bias Modification

LLUBMC

Loma Linda University Behavioral Medicine Center

RBANS

Repeatable Battery for Neuropsychological Status

ANCOVA

Analysis of Covariance

vii

ABSTRACT OF THE DISSERTATION
Evaluating Cognitive Changes in Patients Receiving Outpatient Alcohol Treatment
by
Michelle McDonnell
Doctor of Philosophy, Graduate Program in Clinical Psychology
Loma Linda University, March 2018
Dr. Grace J. Lee, Chairperson

Chronic alcohol use has been linked to various physical health concerns,
neurological changes, and cognitive deficits. Research has shown that some of these
neurologic and cognitive deficits can improve over time following detoxification and
abstinence; however, the exact nature or timeline of this recovery process has not been
established. The aim of the current study is to identify cognitive deficits and changes
present in the alcohol addiction treatment population, the influence of cognitive deficits
on treatment completion, and the effect of previous engagement in treatment (which is
indicative of previous relapse) on cognitive functioning at both treatment onset and
treatment completion. Results suggest that individuals within an intensive outpatient
AUD program experienced improvements in language and overall cognitive functioning.
Additional variables approaching significance include the subtests of story learning,
figure copy, semantic fluency, digit span, coding, and the overall attention index, all of
which exhibited small to medium effect sizes. In contrast, impairments in cognitive
functioning were not related to treatment drop-out. Finally, previous treatment
engagement was not suggestive of worse cognitive functioning. Despite reduced sample
size, these results provide some insight into the variability in cognitive functioning within
AUD, suggesting that providers may need to consider tailoring treatment for those who
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present with various cognitive impairments. Programs that account for memory,
executive functioning, and processing speed impairments may assist their patient’s in the
retention of information presented during treatment, thus improving rehabilitation and
increasing subsequent success in sobriety.
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CHAPTER ONE
INTRODUCTION

The Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM5) specifies that the diagnosis of substance use disorders requires symptoms across four
criteria: impaired control, social impairment, risky use, and pharmacological criteria
(2013). Individuals with a substance use disorder experience impaired control over
substance use, cravings for the substance, failure to fulfill major role obligations,
continued use despite physical or psychological problems, use in situations that may be
physically hazardous, increased tolerance of the substance, and withdrawal symptoms.
Evaluation of rates of abuse and misuse of specific substances reveals that alcohol has the
highest rate of abuse among all drugs (National Council on Alcoholism and Drug
Dependence, 2015).
According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA),
56.9% of people age 18 or older reported drinking alcohol in the past month, while 24.7%
reported engaging in binge drinking, defined as a pattern of drinking that brings blood
alcohol concentration levels to 0.008g/dL (e.g., five or more alcoholic drinks for men
within two hours, four or more alcoholic drinks for women within two hours) within the
past month, and 6.7% reported engaging in heavy drinking, defined as binge drinking on
five or more days in the past month in (NIAAA, 2016). In 2015, approximately 16.3
million adults met criteria for an Alcohol Use Disorder (AUD), and 1.5 million adults
received treatment for an AUD from a specialized chemical dependency treatment
program (NIAAA, 2016). The economic burden of alcohol misuse is considerable, such
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that in 2010, it cost the United States $249 billion. Beyond economics, alcohol misuse
has resulted in the deaths of 88,000 people in the United States and 3.3 million
individuals worldwide in 2012 (NIAAA, 2016).

Physical Health Risks of Alcohol Use
Alcohol misuse has been found to be related to numerous health concerns
including, but not limited to, cancer, pancreatitis, and liver disease. Increased risk of
developing a diagnosis of pancreatitis is dose-related, such that after a threshold of four
drinks per day, the risk of diagnosis increases proportionally to the amount of alcohol
consumed (Irving, Samokhavalov, & Rehm, 2012). Additionally, there is a dose-response
pattern of the effect of alcohol use on risk of cirrhosis of the liver (Day, 2006). This
relationship can be exacerbated by body weight, type II diabetes, and genetic risk factors,
which also may be influenced by alcohol misuse. Further evaluation of liver disease
indicates that the median survival rate for those with a diagnosis of cirrhosis of the liver
is approximately two years with evidence of decompensation and ten years with
compensated cirrhosis; however, survival rates improve significantly with abstinence
(Day, 2006). In regard to cancer, alcohol has been causally linked to squamous cellcarcinoma of the oral cavity, pharynx, larynx, and esophagus. There is a correlational
relationship between alcohol use and colon cancer, liver cancer, and breast cancer, as
well as a confounding relationship between lung cancer and alcohol use, such that
cigarette use increases during alcohol consumption (Boffetta & Hashibe, 2006).
Alcohol misuse is not only costly at economic and global levels, but also to the
individual’s physical and neuropsychological health. Research has indicated that there is
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a J-shaped relationship between alcohol use and health deficits, such that minimal daily
alcohol use may be linked to positive health benefits, while high level consumption is
linked with negative health effects (Di Castelnuovo et al., 2006). Specifically, this dosedependent relationship has indicated that more than one to two drinks per day for women
and two to four drinks per day for men increases risk for negative health concerns (Di
Castelnuovo et al., 2006; O’Keefe, Bybee, & Lavie, 2007). In addition to the negative
impact of chronic misuse of alcohol, those who engage in occasional misuse, such as
binge drinking, also suffer from negative health consequences such as cancer,
pancreatitis, and liver disease (Day, 2006; Irving, Samokhavalov, & Rehm, 2012;
O’Keefe, Bybee, & Lavie, 2007). More specifically, even minimal alcohol consumption
has been linked to increased risk of breast cancer in women (Shield, Soerjomataram, &
Rehm, 2016). These negative effects are also impacted by alcohol type, such that alcohol
consumption, with the exception of wine, is associated with increased risk for liver
cirrhosis (Day, 2006).
In contrast to the negative health risks associated with alcohol use, positive
benefits of minimal to moderate alcohol use, specifically ethanol rather than particular
components of various alcoholic beverages, has been linked to cardiovascular protection
(O’Keefe, Bybee, & Lavie, 2007) and reduced risk for cardiovascular dementia (Deng,
Li, Wang, Gao, & Chen, 2005; Ganguli, Vander Bilt, Saxton, Shen, & Dodge, 2005;
Ruitenberg et al., 2002; Stampfre, Kang, Chen, Cherry, & Grodstein, 2005). Small to
moderate amounts of alcohol consumption has been associated with lower risk of
myocardial infarction, which is hypothesized to be attributed to the relationship between
alcohol and HDL cholesterol, fibrinogen, and insulin sensitivity (Mukamal et al., 2005).
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Small to moderate alcohol consumption is also associated with reduced glucose excursion
in diabetic patients (Turner, Jenkins, Kerr, Sherwin, & Cavan, 2001), due to ethanol’s
tendency to suppress the release of fatty acid from adipose tissue (Greenfield et al.,
2003). The relationship with alcohol consumption and abdominal weight is also
exemplified by a J-shaped relationship, such that those who consume light amounts of
alcohol on a daily basis have less abdominal obesity compared to non-drinkers; however,
more than two drinks per day is associated with greater abdominal obesity in proportion
to the number of drinks consumed per day (Dorn et al., 2003).

Neurological Effects of Chronic Alcohol Use
Alcohol misuse has also been linked to neurologic changes (Bates, Bowden, &
Barry, 2002; Crews & Nixon, 2008; Harper, 2009; Oscar-Berman & Marinkovic, 2007;
Sullivan & Pfefferbaum, 2005). Evidence of alterations in neurological functioning have
been found during intoxication (Crews & Nixon, 2008), periods of binge drinking
(Weissenborn & Duka, 2003), for patients who have been long-term alcohol users (Pitel
et al., 2007), and even in those who are social drinkers that do not meet the criteria for an
AUD (Harper, 2009). Neuroimaging studies have revealed volume loss in the frontal
lobes, cerebellar vermis, and anterior hippocampus, as well as increased ventricular and
sulcal cerebrospinal fluid (Bates, Bowden, & Barry, 2002; Harper, 2009). Evaluation of
MRI and fMRI studies revealed that excessive consumption of alcohol results in patterns
of circuitry disruption between the frontocerebellar neuronal nodes and connecting
circuitry throughout the brain (Sullivan & Pfefferbaum, 2005). Oscar-Berman and
Marinkovic (2007) found up to a 20% decrease in gray matter volume bilaterally in the

4

dorsolateral frontal cortex, as well as gray matter decrease in the temporal cortex, insula,
thalamus, and cerebellum. Research has also found up to 10% decrease in white matter of
the corpus callosum in chronic alcohol users (Chanraud et al., 2007; Oscar-Berman &
Marinkovic, 2007). Neurological changes have also been found in clinically and socially
intact alcohol-dependent individuals, such as alterations of the cerebello-thalamo-cortical
pathways, as well as reduction in brain volume in the dorsolateral frontal lobe, temporal
cortex, insula, thalamus, and cerebellum (Chanraud et al., 2007).
Further evaluation of neuropsychological functioning indicates that patients with
an AUD have significant difficulty when acquiring complex novel information (Pitel et
al., 2007). fMRI studies indicate that, for patients with an AUD, there is increased
cerebellar activation on tasks primarily considered to be associated with frontal lobe
function, despite scoring within normal limits in functioning, which is indicative of a
compensatory strategy (Pitel et al., 2007; Sullivan & Pfefferbaum, 2005). While this
compensatory strategy may produce results within the normal range, it presents as
ineffective and taxing, thus revealing the toll chronic alcohol use takes on the brain.
Additional research indicates that higher-order executive functions are utilized to
compensate for deficits in basic cognitive domain task performance (Pitel et al., 2007;
Scheurich, 2005). More specifically, for recently detoxified men, they utilize frontal
executive systems to perform basic visuospatial processes, such as visual perceptual
learning and recall, to perform at the same level as normal controls, despite the fact that
normal controls utilize more basic processes (Fama, Pfeferbaum, & Sullivan, 2004).
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Neuropsychological Effect of Chronic Alcohol Use
Given the neurological changes associated with alcohol use, and specifically the
structural and functional changes within the frontal cortices, temporal cortices, and
neuronal circuitry throughout the brain, patients’ neuropsychological functioning is also
negatively influenced (Crews et al., 2005; Duka, Townshend, Collier, & Stephens, 2003;
Pitel et al., 2007). The neuropsychological domains that may be affected by functional
changes related to alcohol use include visuospatial functioning, learning and memory,
executive functioning, language, attention, and processing speed.

Visuospatial Functioning
Alcohol use has been associated with deficits in visuospatial abilities (Crews et
al., 2005). Those engaging in moderate to heavy alcohol consumption experience poorer
performance in visuospatial functioning compared to healthy controls (Green et al, 2010).
Patients with AUD exhibit deficits in visuospatial functioning, including the scanning,
construction, and utilization and manipulation of visual information (Beatty et al., 1996).
When compared to healthy controls, recently detoxified patients displayed reduced
performance in the learning and construction, delayed recall, and even recognition of a
complex figure (Dawson & Grant, 2000). Additionally, compared to healthy controls,
recently detoxified patients presented with reduced problem-solving skills in
organization, perceptual clustering, and constructional accuracy, which likely effects their
ability to integrate visuospatial information in a complex design task.
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Learning and Memory
The impact of alcohol use and misuse on learning and memory has proven to be
variable, based on a number of factors, including type of memory and level of alcohol
use. Compared to healthy controls, participants engaging in moderate to heavy alcohol
consumption exhibit poorer performances in immediate memory (e.g., list learning and
story learning; Sullivan, Harris, & Pfefferbaum, 2010). Alcoholic patients have also been
found to exhibit a pattern of moderate impairment across verbal and non-verbal ability
and memory (Tivis, Beatty, Nixon, & Parsons, 1995). When evaluating learning and
memory beyond list learning, alcohol patients exhibit impairments in their ability to learn
complex novel information (Pitel et al., 2007). Patients with severe alcohol misuse
resulting in Korsakoff’s Syndrome (KS) exhibit variations in memory performances such
that they exhibit impairments on tests of explicit memory, particularly those tasks
wherein they are not provided cues (Sullivan, Harris, & Pfefferbaum, 2010), but exhibit
fewer impairments in verbal and non-verbal tests of implicit memory (Sullivan, Harris, &
Pfefferbaum, 2010).

Executive Functioning
Neuropsychological profiles of patients with mild alcoholism are likely to be
more sensitive to frontal lobe damage than social drinkers (Duka, Townshend, Collier, &
Stephens, 2003). Deficits in executive functioning in chronic alcohol use have been found
in cognitive flexibility (Ratti, Bo, Giardini, & Soragna, 2002) and working memory
(Sullivan, Harris, & Pfefferbaum, 2010). The impairments have been found to increase
with level of alcohol use, such that those with higher levels of alcohol consumption
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exhibit greater impairments in perseverative responding, response inhibition, and
cognitive flexibility (Houston et al., 2014). The negative effects of heavy drinking are not
limited to chronic users, but also effect those who engage in binge drinking or social
drinking (Parada et al., 2012; Weissenborn & Duka, 2003). Binge drinkers have been
found to exhibit impairments in executive functioning and the ability to retain and
manipulate verbal working memory (backward digit span; Parada et al., 2012), while
those who engage in acute or social alcohol use also demonstrate impairments in
executive functioning (Weissenborn & Duka, 2003).

Language, Attention, and Processing Speed
Results concerning deficits with regard to language, attention, and processing
speed are variable. With regard to language, alcoholic participants showed relative
sparing in the domain of language functioning (Crews et al., 2005). In terms of attention,
over an eight-year period, adolescents and young adults who qualify for a diagnosis of
alcohol use disorder exhibit a decline in attentional abilities, with increased decline
associated with longer period of use (Tapert, Granholm, Leedy, & Brown, 2002). Patients
who have recently completed detoxification exhibit deficits in attention; furthermore,
those who resume drinking after detoxification continue to exhibit deficits in attention
(Bourke & Grant, 1999). With regard to processing speed, alcohol patients have been
found to experience a pattern of moderate impairments in perceptual motor skill (Tivis,
Beatty, Nixon, & Parsons, 1995), with heavier drinking being associated with increased
slowing in psychomotor speed (Houston et al., 2014). Recently detoxified male alcohol
patients also experience deficits in psychomotor processing speed, which is further
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exacerbated with resumed alcohol consumption after detoxification (Bourke & Grant,
1999). This pattern continues with older male adults, such that deficits increase with age
and older male adults perform significantly worse than their same-age peers on measures
of psychomotor processing compared to the discrepancy found in younger males (Bourke
& Grant, 1999).

Recovery of Function after Abstinence
Despite the neurological and neuropsychological deficits associated with alcohol
use and AUDs, selective functional improvements and some recovery of brain mass have
been found as a result of abstinence (Crews et al., 2005). Research has revealed that
neurogenesis occurs during abstinence (Crews et al., 2005), and cell proliferation across
multiple brain regions has been shown to occur as early as the first day of abstinence
(Crews & Nixon, 2008). Nixon, Kim, Potts, He, and Crews (2008), reported cell
proliferation throughout the hippocampus and cortex after approximately two days of
abstinence, and as the person remains abstinent, there is increased cell proliferation
throughout the cortex by 28 days of sobriety. MRI studies have revealed that recovering
patients with an AUD show greater white matter volumes in the frontal lobes, greater
cortical gray matter in the orbital frontal pole and somatosensory cortex, as well as
reduced white matter volume in the frontal lobes, compared to active heavy drinkers
(O’Neill, Cardenas, & Meyerhoff, 2001). Notably, frontal lobe changes are potentially
reversible with abstinence for several months or years (Moselhy, Georgiou, & Khan,
2001).
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As neurological functioning and brain structures recover in abstinence, so too
does cognitive function (Mann, Gunther, Stetter, & Ackermann, 1999). Patients who have
received outpatient alcohol treatment exhibit improvements in executive functioning,
verbal ability, and information processing after six weeks of abstinence; however, due to
the small effect size, improvement may not be considered clinically significant (Bates,
Voelbel, Buchman, Labouvie, & Barry, 2005). A meta-analysis revealed that cognitive
deficits were still present in eleven cognitive domains, including language verbal fluency,
processing speed, working memory, attention, executive functioning, verbal learning and
memory, and visual learning and memory after just one month of abstinence; however,
these deficits were resolved after one year of abstinence, even for participants who began
treatment with minimal neuropsychological difficulties (Oscar-Berman & Marinkovic,
2007; Stavro, Pelletier, & Potvin, 2011). Similarly, long-term abstinent males with a
previous AUD, who remained abstinent for two years, exhibited similar
neuropsychological results compared to healthy controls (Bourke & Grant, 1999). While
research has shown some cognitive improvements with long-term periods of abstinence
(e.g., six months to a year), results assessing the older veteran population found that
within the early stages of recovery (e.g., first two months of abstinence) they still exhibit
deficits in verbal and nonverbal learning, with verbal learning being profoundly impaired
(e.g., two standard deviations below same-age peers) across the learning trials, despite
experiencing a time of abstinence (Bell, Vissicchio, & Weinstein, 2016). These results
suggest that cognitive recovery is dependent upon time since abstinence.
Research has been mixed with regard to the cognitive domains that undergo
improvement. Mann, Gunther, Stetter, and Ackermann (1999) reported that after
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approximately five weeks, the performance discrepancy between control participants and
patients engaged in alcohol abstinence was reduced, with the exception for verbal shortterm memory. In contrast, Fein, Backhman, Fisher, and Davenport (1990), indicated that
impairments in cognitive functioning have been found across the first five months of
abstinence, such that half to two-thirds of abstinent alcohol exhibit these impairments;
however, these deficits have been found to last for years after detoxification, with
visuospatial functioning, psychomotor speed, abstract reasoning, and new learning
experiencing the greatest impairments.
The pattern of cognitive impairment in abstinence is impacted influenced by a
number factors, including time since detoxification and age of onset of alcohol use (Fein,
Bachman, Fisher, & Davenport, 1990). Specifically, those in acute detoxification (zero to
two weeks of abstinence), exhibit deficits in attention, concentration, reaction time, motor
coordination, motor speed, judgment, problem-solving, learning, and short-term memory
(Fein, Bachman, Fisher, & Davenport, 1990). Patients in the intermediate-term of
abstinence (two weeks to two months) exhibit persistent deficits in visuospatial
processing and problem-solving. In some cases, the ability to learn new verbal material
improves within the first two weeks of abstinence; however, it remains impaired after one
month. Patients in the stages of long-term abstinence (greater than two months)
experience variable results, such that while there are still improvements in cognitive
functioning, the level of improvement varies across domain and may still not reach the
level of same-age controls. Research is mixed with regard to improvements in long-term
abstinence, such that some researchers indicate that cognitive deficits remain after one
year of abstinence (Stavro, Pelletier, & Potvin, 2011).
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Age of onset of alcohol use has shown to be associated with cognitive
impairment, such that those who begin drinking at a mean age of 14 experience
significantly more severe impairments than those with a mean age of onset of 23,
controlling for number of years of heavy drinking (Fein, Bachman, Fisher, & Davenport,
1990). Within six-months, improvements in episodic memory and executive functioning
performances can return to normal; however, this is influenced by length of alcohol
misuse, such that those with shorter length of alcohol use and misuse experience greater
improvements in episodic memory recovery (Pitel et al., 2009). The reversal in cognitive
deficits throughout abstinence and AUD recovery indicates that that the brain may be
capable of repair and restructuring throughout adulthood (Crews et al., 2005).
Results indicate that with abstinence, many individuals with significant cognitive
deficits exhibit at least a partial recovery from their alcohol-related cognitive impairment
(Bates, Buckman, & Nguyen, 2013). Beyond abstinence, cognitive training has been
associated with reduced risk for alcohol relapse up to one year after treatment (VerdejoGarcia, 2016). Specifically, Cognitive Bias Modification (CBM), a treatment aimed at
modifying cognitive biases and changing how one thinks and mentally responds to
everyday occurrences, has been found to reduce long-term alcohol use (Verdejo-Garcia,
2016). CBM has also been found to significantly reduce medial prefrontal cortex
activation, which has been associated with alcohol-approach bias. Additionally, cognitive
rehabilitation may assist in the recovery of cognitive functioning when patients are
provided domain specific tasks, such as copying figures, decoding rhythmic signals,
attending to and interpreting orally presented stories, multi-tasking, visual reasoning,
recalling stories, completing crossword puzzles, and developing mnemonic strategies
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(Allen, Goldstein, & Seaton, 1997). Cognitive rehabilitation has been linked to improved
performance in executive functioning, memory, and other cognitive abilities, which thus
influence the behavioral outcomes of treatment, such as abstinence and interpersonal
relationships (Bates, Buckman, & Nguyen, 2013).

Factors Related to Treatment Outcome
Neuropsychological functioning is essential for daily functioning and has been
found to be related to treatment outcome (Tapert, Ozyurt, Myers, & Brown, 2016). Those
who exhibit deficits in verbal learning are likely to experience reduced effectiveness of
verbally-based interventions and psychoeducation, thus affecting their long-term
recovery (Bell, Vissiccio, & Weinstein, 2016). Research has found that neurocognitive
abilities moderate the relationship between coping and treatment outcome, such that those
with poorer neurocognitive functioning are likely to have poorer treatment outcomes
(Tapert, Ozyurt, Myers, & Brown, 2016). These results are likely due to the fact that
alcohol-dependent adults with neuropsychological deficits may have more difficulty
utilizing adaptive coping skills (Tapert, Ozyurt, Myers, & Brown, 2016). Additionally,
chronic alcohol users also suffer impairments in prospective memory for both short-term
and long-term events, which may also influence long-term recovery (Heffernan, Moss, &
Ling, 2002). Given the findings that poorer neurocognitive functioning is predictive of
poorer treatment outcome, evaluation of cognitive changes within treatment are
necessary. It will be essential to determine the neurocognitive status and changes in
patients receiving treatment for an AUD to ensure that they have access to the best
treatment outcomes possible.
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Impact of Relapse on Health and Recovery
It has been noted that relapse rates within a population of alcohol-dependent
patients is high, such that up to 85% of the patients will relapse, even years after
treatment. (Wiers & Heinz, 2015). Evaluation of neuroimaging suggests that, compared
to individuals maintaining abstinence, those who relapse have been found to have
relatively smaller volume in the orbitofrontal cortex and medial prefrontal cortex (Wiers
& Heins, 2015), as well as altered connectivity responses in the anterior cingulate cortex
(Zakiniaeiz, Scheinost, Seo, Sinha, & Constable, 2017). Neuroimaging studies also report
structural changes within the amygdala, which is associated with increased craving for
alcohol, in those who relapse compared to abstainers (Wiers & Heinz, 2015). Even
previous relapses and detoxifications are associated with subsequent relapse behavior, as
those with multiple previous detoxifications drink more intensely than patients without
previous detoxifications (Malcolm, Roberts, Wang, Myrick, & Anton, 2000). Overall,
those with less cortical volume are more likely to drink heavily during relapse (Naqvi &
Morgenstern, 2015). This suggests that these patients are drinking significantly more
alcohol prior to their abstinence, which may ultimately influence their cognitive
functioning.
Given the complexity of recovery, it is notable that relapse can be impacted by a
number of factors (e.g., psychosocial, neurological); however, diminished cognitive
abilities likely add to the difficulty of maintaining abstinence (Stavro, Pelletier, & Potvin,
2012). Evaluation of neurocognitive functioning suggests that individuals with poorer
general cognitive skills and decision-making are at an increased risk for subsequent
relapse (Dominguez-Salas, Diaz-Batanero, Lozano-Rojas, & Verdejo-Garcia, 2016).
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Beyond overall or general cognitive functioning, research has indicated that specific
cognitive domains are also implicated in relapse rates. More specifically, those who have
undergone more than one detoxification of alcohol experience increased impairments in
visuospatial abilities, learning and memory, attentional problems, and primarily executive
functioning (Duka, Townshend, Collier, & Stephens, 2003). Additionally, within the
domains of episodic memory and executive functioning, those who relapse not only
perform significantly worse than abstainers, but also perform worse than their own
baseline performance (Pitel et al., 2009). Working memory (as exhibited by a task such
as the n-back task) has also been identified as indicative of subsequent relapse, with poor
performance related to increased risk for relapse (Wiers & Heinz, 2015). Individuals who
relapse do not show improvements in cognitive functioning or brain volume, as do those
who remain abstinent (Pfefferbaum et al., 1995). These studies suggest that previous
relapse largely impacts subsequent neurological and cognitive functioning. Given the
influence of cognitive functioning on overall recovery and health, it will be important to
determine if previous relapse is associated with worse cognitive performance, suggestive
of reduced recovery success.

Aims and Hypotheses
The first aim of this study is to evaluate the neurocognitive deficits and changes
across treatment for patients receiving intensive outpatient treatment for an AUD. It is
hypothesized that patients will exhibit improvements in their cognitive functioning at the
end of their alcohol treatment, particularly in the domains of immediate memory, delayed
memory, visuospatial functioning, and processing speed. The second aim of this study is
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to identify if cognitive deficits present at the beginning of treatment are predictive of
treatment completion. It is hypothesized that patients with poorer cognitive performance
will have poorer treatment completion rates. The third and final aim of this study is to
evaluate the cognitive performance within those who have undergone previous
detoxification for AUD. Notably, it is hypothesized that overall cognitive abilities, as
well as specific cognitive domains such as attention and memory (i.e., immediate and
delayed) will be significantly worse for a those who have experienced previous periods of
formal detoxification, across time points (i.e., onset of treatment, completion of
treatment).
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CHAPTER TWO
METHOD

Participants
Participants were selected from the Loma Linda University Behavioral Medicine
Center (LLUBMC), from a pool of patients who completed a seven-day inpatient
detoxification program at the LLUBMC and received intensive outpatient chemical
dependency treatment strictly for alcohol use disorder. Participants who qualified for
enrollment were selected by the chemical dependency director at the LLUBMC. All
participants were detoxified and medically stable at outpatient treatment entry.
Participants aged 20-89 were included in this study.
The final sample comprises 57 adults seeking intensive outpatient alcohol
addiction treatment (age 26 to 64 years, M = 47.39, SD = 10.37; 49.1% female). In the
current sample, 43 successfully completed their alcohol treatment, and of those 43, 20
participants (age 26 to 63 years, M = 49.80, SD = 10.84; 55% female) were successfully
tested after approximately three weeks of treatment.

Procedures
Participants of the chemical dependency treatment program were recruited for the
study within two days of admission to the outpatient program, after completing an
inpatient detoxification at the LLUBMC. Upon enrollment in the study, written informed
consent was obtained in accordance with the procedures set by the Loma Linda
University Institutional Review Board. Participants were then administered the
Repeatable Battery for Neuropsychological Status (RBANS), as well as a structured
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clinical interview regarding demographic information, as well as health, drug, and legal
history. Participants were then re-evaluated approximately three weeks later, at the end of
their treatment, to assess for any changes in cognitive functioning.

Measures
The RBANS (Randolph, 1998) is a brief, individually administered assessment
battery that assesses the neuropsychological status of adults with neurologic injury or
disease. There are 12 subtests of the RBANS: list learning, story memory, figure copy,
line orientation, digit span, symbol digit coding, picture naming, semantic fluency, list
recall, list recognition, story recall, and figure recall. The 12 subtests assess different
areas of cognitive function that result in five indices: immediate memory,
visuospatial/constructional, language, attention, and delayed memory. The Immediate
Memory Index is composed of list learning and story memory. The Visuospatial Index is
composed of figure copy and line orientation. The Language Index is comprised of
picture naming and semantic fluency. The Attention index includes the digit span and
coding subtests. Finally, the Delayed Memory Index is composed of list recall, list
recognition, story recall, and figure recall. A total scale score provides a global measure
of neuropsychological functioning. The RBANS utilizes a United States population-based
normative standardization, and index scores are scaled using age-based norms. The
RBANS has been found to demonstrate sufficient validity and reliability within the
clinical populations of dementia (i.e., Alzheimer’s, vascular, HIV, Huntington’s,
Parkinson’s), depression, schizophrenia, and traumatic brain injury (Randolph, 2006).
External research also indicated that the RBANS demonstrates good validity for patients
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within the following clinical populations: end-stage liver disease (Mooney et al., 2007),
schizophrenia (Gold, Queern, Iannone, & Buchanan, 1999; Wilk et al., 2004), stroke
(Green, Sinclair, Rodgers, Birks, & Lincoln, 2013), and traumatic brain injury (McKay,
Casey, Wetheimer, & Fichtenberg 2006).

Analyses
Evaluation of the relationship of the sample demographics (e.g., gender, ethnicity,
years of education) and cognitive performance was will be conducted. Evaluation of
group differences for treatment completers and non-completers was conducted to
determine if differences within demographic variables exist. Lastly, evaluation of the
relationship between demographic variables and previous alcohol treatment was
conducted. As there were significant differences among groups and cognitive factors,
such variables were controlled for in subsequent analyses. Of note, age-adjusted z-scores
and index scores were utilized for RBANS data, and thus age was not included as a
covariate.
The first aim of this study was to identify the cognitive changes present in patients
receiving intensive outpatient treatment. It was hypothesized that participants will show
improvements in the domains of immediate memory, delayed memory, visuospatial
functioning, and processing speed. Repeated Measures Analysis of Covariance was
conducted, comparing within-subject changes, to evaluate the effect of treatment on
cognitive functioning (DV) across time points (IV) within RBANS Total Scores, Index
Scores, and individual subtests. Should the demographic variables of gender, years of
education, and ethnicity show significant relationship with variables of cognitive
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performance, they will be controlled within the analyses. Additionally, we calculated
Bonferroni Corrections to correct for the elevated risk of Type 1 error. Finally, reported
effect sizes (partial eta squared) to determine the strength of any significant differences.
The second aim of this study was to identify if cognitive deficits present at the
beginning of treatment are associated with treatment completion. It was hypothesized that
participants with more prominent cognitive functioning deficits will have increased rates
of treatment dropout. Independent samples t-tests were conducted to evaluate if cognitive
deficits are related to dropout rates. Specifically, we evaluated each cognitive domain and
categorical index to determine if there was a relationship between cognitive performance
and subsequent completion of treatment. Analyses were conducted with all participants at
the first-time point (n = 57) utilizing Treatment Completion as the independent variable.
We conducted 18 independent samples t-tests and reporting effect sizes (Cohen’s d) to
determine the strength of these differences. Additionally, Bonferroni correction was
utilized to correct for Type I error.
The third aim of this study was to identify if there was a relationship between
exposure to previous formal alcohol treatment and cognitive functioning. It was
hypothesized that participants with previous formal treatment exposure will exhibit
reduced cognitive functioning, specifically within overall cognitive functioning,
attention, and memory (immediate and delayed), across time points. Analysis of
Covariance (ANCOVA), controlling for ethnicity, years of education, and gender, was
conducted to evaluate if those with previous treatment exposure will have reduced
cognitive functioning compared to those without previous treatment exposure. Effect
sizes (eta squared) was also be reported to indicate the strength of the relationship.
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CHAPTER THREE
RESULTS

Evaluation of the relationship between demographics and variables of cognitive
performance was conducted. Results of correlation analyses revealed significant
relationships between gender, education, and ethnicity, and various indices and individual
subtests of cognitive functioning (see Table 1). Thus, these variables were controlled for
in the repeated measures analysis used to investigate the first and third aim. Evaluation of
demographic differences among treatment completers and non-completers was
conducted. Results of Chi-Square analyses did not reveal significant differences among
those who did and did not complete treatment for the variables of gender, ethnicity, or
education (see Table 2). Additionally, an Independent Samples t-test showed that there
were no significant differences between completers and non-completers for age (see
Table 2). A Pearson Correlation was conducted, revealing no significant relationship
between previous rehabilitation experience and demographic variables (years of
education, gender, and ethnicity). Finally, there were no significant differences among
demographic variables or baseline RBANS scores between the individuals who
completed treatment and the second time point of testing compared to those who
completed treatment without completing the second time point of testing (see Table 3).
Given the lack of significant relationship between demographics variables and those who
did and did not complete treatment, no demographic variables were controlled for in the
second aim of this study.
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Table 1. Pearson Correlations between Demographics and Cognitive Variables at the Start
and End of Treatment.
Start Treatment
End Treatment
Gender Ethnicity Education Gender Ethnicity Education
-0.11
0.41**
-0.25
-0.59**
0.30
Immediate Memory 0.19
Index
List Learning
0.13
-0.04
0.36**
-0.06
-0.50*
0.38
Story Memory
0.26
-0.16
0.40**
-0.21
-0.36
0.05
-0.03
-0.15
-0.40**
-0.41
-0.11
0.12
Visuospatial Index
Figure Copy
-0.02
-0.08
0.37**
-0.42
-0.13
-0.11
Line Orientation
0.01
-0.00
0.20
-0.24
-0.04
0.41
0.18
0.09
0.27
-0.39
-0.35
-0.13
Language Index
Semantic Fluency 0.42**
0.07
0.25
-0.34
-0.22
-0.19
Picture Naming
-0.04
-0.24
0.22
-0.35
-0.73**
0.35
0.31*
0.16
0.21
-0.03
-0.34
-0.17
Attention Index
Digit Span
0.18
0.05
-0.01
-0.35
-0.42
-0.28
Coding
0.41**
0.15
0.27*
0.16
0.07
-0.08
0.07
-0.18
0.36**
-0.02
-0.35
0.54*
Delayed Memory
Index
List Recall
0.24
-0.07
0.30*
0.05
-0.15
0.53*
List Recognition
-0.02
-0.33*
0.17
-0.11
-0.59**
0.33
Story Recall
0.23
0.03
0.33*
-0.01
0.09
0.36
Figure Recall
0.07
0.01
0.34**
-0.06
0.02
0.13
0.24
-0.07
0.49**
-0.34
-0.43
0.16
Total Scale
*p < .05. **p < .01.

Table 2. Chi-Square and Independent Samples t-test Evaluating Group Differences
(Treatment Completion vs. Non-Completion) in Demographic Variables.
t
p
d
Age
-1.08
0.28
0.45
X2
p
Φ
Gender
3.14
0.07
0.24
Ethnicity
1.26
0.53
0.15
Education
6.01
0.20
0.33
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Table 3. Independent Samples t-test Evaluating Differences in Demographic and RBANS
Baseline Variables for Within Treatment Completers (Second Testing vs. Non-Second
Testing).
t
p
d
Post-Hoc
Power
Age
-0.61
0.54
0.19
0.09
Gender
-0.24
0.81
0.07
0.06
Education
-1.69
0.10
0.52
0.38
-0.12
0.91
0.04
0.05
Immediate Memory Index
List Learning
-0.37
0.71
0.11
0.06
Story Memory
0.25
0.80
0.08
0.10
0.20
0.84
0.06
0.08
Visuospatial Index
Figure Copy
1.71
0.10
0.52
0.38
Line Orientation
-0.99
0.33
0.31
0.17
-0.60
0.55
0.19
0.09
Language Index
Semantic Fluency
-0.06
0.96
0.02
0.05
Picture Naming
-0.72
-0.48
0.23
0.11
0.71
0.48
0.22
0.11
Attention Index
Digit Span
1.21
0.23
0.38
0.23
Coding
0.84
0.40
0.26
0.13
0.65
0.52
0.20
0.10
Delayed Memory Index
List Recall
-0.41
0.69
0.12
0.07
List Recognition
0.99
0.33
0.30
0.16
Story Recall
-0.18
0.86
0.06
0.05
Figure Recall
-0.27
0.79
0.08
0.06
0.41
0.68
0.13
0.07
Total Scale

Evaluation of the RBANS variables (subtests and indices) across both time points
revealed that the following variables failed tests of normality: line orientation (treatment
onset), picture naming (across time points), list recognition (across time points), and the
immediate memory index (post treatment). Subsequently, the variables were transformed
using a Log transformation (log(Xi)) in an attempt to overcome problems of outliers,
skewness, and kurtosis. The transformations successfully rectified problems with line
orientation, list recognition, and list recognition; however, the variables of picture naming
(across time points), and immediate memory index (post treatment) continued to
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demonstrate difficulties with skewness and kurtosis. Subsequently, the Square Root and
Reciprocal Transformations were applied to the remaining variables, revealing that they
continued to deviate from a comparable normal distribution. As such, picture naming and
immediate memory were not utilized in the evaluation of cognitive changes across
treatment. Of note, there did not appear to be any significant outliers impacting the
remaining variables of interest, therefore no participants were deleted from these results.
To evaluate the cognitive changes within patients receiving intensive outpatient
treatment, 16 Repeated Measures Analysis of Covariance were conducted, one for each
domain and index (with the exception of the variables that failed tests of normality),
controlling for gender, years of education, and ethnicity. Note, age was not controlled for
as we utilized age-adjusted normative data for the cognitive variables. Results indicated
that the intensive outpatient treatment had a statistically significant effect on cognitive
functioning on the indices of Language, F(1, 19) = 14.94, p = 0.04, 𝜂𝑝2 = 0.48, Attention,
F (1,19) = 8.49, p = 0.01, 𝜂𝑝2 = 0.35, the individual subtests of Story Learning F (1, 19) =
10.09, p = 0.006, 𝜂𝑝2 = 0.39, Figure Copy F(1, 19) = 7.10, p = 0.02, 𝜂𝑝2 = 0.31, Digit Span,
F(1,19) = 4.33, p = 0.05, 𝜂𝑝2 = 0.21, and Coding, F(1,19) = 56.37, p = 0.02, 𝜂𝑝2 = 0.29, as
well as the overall Total Scale F(1,19) = 17.01, p = 0.001, 𝜂𝑝2 = 0.52. The effect sizes of
these analyses were found to indicate medium to large effects, suggesting that the
variables evaluated explain 21-52% of the variance in changes of cognitive functioning
(see Table 4). Post-hoc power analyses noted that the significant variables had 50-97%
chance of detecting a true difference. Given the minimal sample size utilized in this
study, a Bonferroni Correction was conducted to correct for the possibility of Type I
error, yielding an alpha value of 0.003. Subsequent review of the results suggested that
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there was still a significant effect of intensive outpatient treatment on the Language Index
and Total Scale (see Table 4), while the individual subtests of Story Learning (p = 0.006)
and Semantic Fluency (p = .004) were approaching significance. Notably, a Wilcoxon
Signed-Rank Test was conducted to evaluate the changes in cognitive functioning for the
variables that failed the tests of normality. Results indicated that the intensive outpatient
treatment program did not elicit a statistically significant change in the Immediate
Memory Index (p = 0.12) or the Picture Making subtest (p = 1.00) for those enlisted a
AUD treatment program.
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Table 4. Repeated Measures Analysis of Covariance Evaluating Effect of Intensive
Outpatient Treatment on Cognitive Functioning, Controlling for Gender, Education, and
Ethnicity.
Start
End
F (p-value)
𝜂𝑝2 Post-Hoc
Treatment
Treatment
Power
M (SD)
M (SD)
----Immediate Memory Index b
List Learning
-0.4 (1.2)
0.1 (0.8)
3.15 (0.09)
0.16
0.39
Story Learning
-0.3 (1.1)
0.2 (0.6)
10.09 (0.006*) 0.39
0.85
Visuospatial Index 85.6 (15.9) 92.9 (17.9)
0.63 (0.44)
0.04
0.12
Figure Copy
-2.3 (1.9)
-1.6 (1.9)
7.10 (0.02*)
0.31
0.71
a
Line Orientation
0.3 (0.2)
0.3 (0.2)
2.65 (0.12)
0.14
0.21
Language Index
98.0 (12.1)
97.8 (12.4)
14.94 (0.001**) 0.48
0.95
b
Picture Naming
-----Semantic Fluency
0.0 (1.2)
-0.0 (1.2)
11.529 (.004*) 0.42
0.89
Attention Index
94.7 (12.5)
102.5 (11.9)
8.49 (0.01*)
0.35
0.78
Digit Span
-0.2 (0.9)
0.0 (1.0)
4.33 (0.05*)
0.21
0.50
Coding
-0.4 (0.9)
0.2 (1.2)
6.37 (0.02*)
0.29
0.66
Delayed
93.2 (14.9)
99.8 (12.3)
0.08 (0.78)
0.01
0.06
Memory Index
List Recall
-0.3 (1.4)
0.0 (1.1)
0.01 (0.94)
0.00
0.05
a
List Recognition
0.2 (0.3)
0.2 (0.2)
0.57 (0.46)
0.03
0.07
Story Recall
-0.2 (1.3)
0.3 (0.7)
1.64 (0.22)
0.09
0.23
Figure Recall
-0.6 (1.1)
0.1 (1.2)
0.30 (0.59)
0.02
0.08
Total Scale Index
90.5 (10.8)
98.2 (11.5)
17.01 (0.001**) 0.52
0.97
a
Log Transformation applied to denoted variable.
b
Log Transformation applied to denoted variable and found to be unsuccessful. Variable
excluded from subsequent analysis.
*p < .05. ** p < .003 based on Bonferroni Correction.

To evaluate whether completers and non-completers demonstrated different levels
of cognitive functioning at baseline, 16 Independent Samples t-tests were conducted.
Results revealed that the poor performances on the Attention Index at baseline (t[55] =
-2.00, p = 0.05, d = -0.54; see Table 3) was related to subsequent treatment completion.
Evaluation of the effect size for the Attention Index, revealed that those who did not
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complete treatment had a medium magnitude of effect (54%) for reduced attention. Posthoc power analyses suggested that there was a 41% chance that results capture a true
difference. Of note, while none of the individual subtests were related to subsequent
treatment completion, Coding (t[55] = -1.72, p = 0.09, d = -0.46) and Digit span (t[55] = 1.86, p = 0.07, d = -0.50) showed a slight trend toward significance (see Table 4). In
contrast, when evaluating these results utilizing the Bonferroni Correction (α = 0.003),
calculated by dividing the number of tests analyzed by 0.05, results revealed that none of
the cognitive domains or indices were related to treatment completion (see Table 5 and
Table 6). A Mann-Whitney U Test was conducted to evaluate if there were significant
differences between treatment completers and non-completers at baseline for the
variables that failed tests of normality; there was no statistically significant differences
for the Immediate Memory Index (p = 0.22) or the Picture Naming subtest (p = 0.50).

Table 5. Independent Samples t-Test Comparing Cognitive Performance in Cognitive
Domains among Those Who Did and Did Not Complete Treatment.
Treatment Mean SD
t
df
p
Cohen’s Post-Hoc
Completion
d
Power
a
Immediate Memory Index
-------Visuospatial Index
Yes
85.9 17.1 0.3 55 0.77
0.08
0.06
No
87.4 16.5
Language Index
Yes
96.0 11.9 -0.2 55 0.82
-0.06
0.05
No
95.2 10.4
Attention Index
Yes
97.3 15.7 -2.0 55 0.05*
-0.54
0.41
No
87.1 18.8
Delayed Memory
Yes
93.9 13.3 -1.5 55 0.14
-0.41
0.26
Index
No
87.2 17.0
Total Scale
Yes
90.8 12.5 -1.4 55 0.15
-0.40
0.25
Index
No
84.9 15.4
a
Log Transformation applied to denoted variable and found unsuccessful. Log
Transformation applied to denoted variable and found to be unsuccessful. Variable
precluded from subsequent analysis.
*p < .05. ** p < .003 based on Bonferroni correction.
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Table 6. Independent Samples t-Test Comparing Performances in Individual Subtests
among Those Who Did and Did Not Complete Treatment.
Treatment Mean SD
t
df
p
Cohen’s Post-Hoc
Completion
d
Power
List Learning
Yes
-0.5 1.1 -1.0 55 0.32
-0.27
0.14
No
-0.9 -0.5
Story Memory
Yes
-0.2 1.0 -0.9 55 0.37
-0.24
0.12
No
-0.6 1.3
Figure Copy
Yes
-1.8 1.8 0.4 55 0.72
0.10
0.06
No
-1.6 1.8
Line Orientation a
Yes
0.4
0.2 -0.1 55 0.91
-0.03
0.05
No
0.3
0.2
Picture Naming b
-----------Semantic Fluency
Yes
-0.1 1.3 -0.9 55 0.37
-0.24
0.12
No
-0.4 1.1
Digit Span
Yes
0.1
1.1 -1.9 55 0.07
-0.50
0.36
No
-0.5 1.0
Coding
Yes
-0.2 1.2 -1.7 55 0.09
-0.46
0.31
No
-0.8 1.4
List Recall
Yes
-0.4 1.1 -0.0 55 0.97
-0.01
0.05
No
-0.4 1.1
List Recognition a
Yes
0.2
0.2 1.5 55 0.15
0.39
0.24
No
0.3
0.3
Story Recall
Yes
-0.3 1.2 -1.1 55 0.27
-0.30
0.16
No
-0.7 1.5
Figure Recall
Yes
-0.7 1.0 -0.5 55 0.60
0.28
0.15
No
-0.9 1.4
a
Log Transformation applied to denoted variable.
b
Log Transformation applied to denoted variable and found to be unsuccessful. Variable
precluded from subsequent analysis.
*p < .01. **p < .003 based on Bonferroni Correction.

Subtest and Index scores were transformed into dichotomous variables (i.e.,
categorized as impaired [z <= -1.38] or intact [z => -1.37]). Subsequently, three Binary
Logistic Regressions were conducted, ensuring independence of observations (i.e.,
immediate and delayed domains, overall indices), evaluating effects of baseline cognitive
functioning on treatment completion. The data was reviewed and met all assumptions
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necessary to conduct binary logistic regressions. The binary logistic regression model
was statistically significant for the total scale, X2(1) = 2.884, p < 0.05. In contrast, the
individual indices and subtests remained statistically non-significant (see Table 7). Of
note, when these results were evaluated utilizing the Bonferroni Correction (α = 0.0028),
none of the variables was statistically significant, suggesting that baseline cognitive
performance was not associated with treatment completion.

Table 7. Results of Binary Logistic Regression Predicting Treatment Completion from
Performance on Individual Subtests and Overall Indices.
95% CI
Wald
OR
p-value
Lower
Upper
Immediate Memory Index 0.18
1.40
0.67
-2.34
3.28
List Learning
0.01
1.10
0.91
-35.64
2.45
Story Memory
0.49
0.39
0.48
-76.50
23.41
Visuospatial Index
0.59
0.59
0.44
-3.47
1.09
Figure Copy
0.38
0.87
0.85
-19.97
1.62
Line Orientation
1.77
0.13
0.18
-70.47
1.05
Language Index
0.12
0.65
0.73
-22.21
3.10
Semantic Fluency
0.32
1.72
0.57
-22.55
35.74
Picture Naming
0.96
2.78
0.33
-19.48
36.68
Attention Index
0.58
1.84
0.45
-2.34
3.28
Digit Span
0.37
1.86
0.54
-40.04
39.42
Coding
1.93
4.49
0.17
-22.28
72.71
Delayed Memory Index
-0.02
-0.14
1.00
3.48
2.19
List Recall
0.00
0.97
0.98
-20.75
2.17
List Recognition
0.42
0.83
0.84
-20.88
1.89
Story Recall
2.38
3.13
0.12
-0.35
3.06
Figure Recall
2.20
2.71
0.14
-0.62
3.20
Total Scale
3.94
3.86
0.04*
-0.23
2.88
*p < .05. **p < .0028 based on Bonferroni correction.

In order to determine if engaging in previous alcohol treatment, indicative of
multiple relapses, influences cognitive functioning, two ANCOVAs were computed.
Results revealed that when controlling for gender, years of education, and ethnicity,
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previous treatment enrollment, indicative of previous relapse, was not significantly
associated with subsequent cognitive impairments for any subtests or indices (see Table 8
and Table 9). A Mann-Whitney U Test also revealed that previous relapse was not
significantly associated with cognitive impairments for the Immediate Memory Index (p
= 0.76) or the Picture Naming subtest (p = 0.46).
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Table 8. Analysis of Covariance (ANCOVA) Testing Mean Differences in Baseline Cognitive
Functioning Between Individuals Who Did and Did Not Attend Previous Alcohol Treatment,
Controlling for Ethnicity, Education, and Gender.
Previous Treatment
Yes (n = 30)
No (n = 27)
M (SD)
M (SD)
F(1, 55) p-value Partial Post-Hoc
η2
Power
b
Immediate Memory Index
------List Learning
-0.41 (1.16)
-0.87 (1.10)
0.05
0.83
0.00
0.05
Story Memory
-0.40 (1.26)
-0.27 (0.86)
0.13
0.72
0.01
0.12
Visuospatial Index
88.10 (18.31) 84.19 (15.11)
0.89
0.36
0.06
0.47
Figure Copy
-1.64 (1.89)
-1.90 (1.60)
0.12
0.74
0.01
0.12
a
Line Orientation
0.32 (0.22)
0.37 (0.21)
0.05
0.83
0.00
0.05
Language Index
97.32 (9.44) 94.15 (13.38)
0.77
0.39
0.05
0.40
Semantic Fluency
-0.01 (1.27)
-0.34 (1.24)
0.07
0.80
0.01
0.12
Picture Naming b
------Attention Index
94.47 (17.83) 95.19 (16.22) 1.41
0.25
0.09
0.64
Digit Span
-0.11 (1.20)
-0.07 (1.06)
0.89
0.36
0.06
0.47
Coding
-0.44 (1.19)
-0.25 (1.34)
0.52
0.28
0.03
0.26
Delayed Memory Index 94.50 (14.93) 89.70 (13.70) 0.32
0.58
0.02
0.18
List Recall
-0.63 (1.22)
-0.53 (1.04)
1.06
0.18
0.12
0.78
a
List Recognition
0.17 (0.25)
0.24 (0.25)
0.02
0.90
0.00
0.05
Story Recall
-0.52 (1.39)
-0.29 (1.15)
0.80
0.39
0.05
0.40
Figure Recall
-0.63 (1.22)
-0.89 (0.99)
0.62
0.44
0.04
0.33
Total Scale
91.27 (14.73) 87.26 (11.63)
0.24
0.63
0.02
0.18
a
Log Transformation applied to denoted variable.
b
Log Transformation applied to denoted variable and found to be unsuccessful. Variable precluded
from subsequent analysis.
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Table 9. Results of ANCOVAs Testing Mean Differences in Post-treatment Cognitive Functioning between Individuals who Did and
Did Not Attend Previous Alcohol Treatment, Controlling for Ethnicity, Education, and Gender.
Previous Treatment
Yes (n = 9)
No (n = 11)
M (SD)
M (SD)
F(1, 18)
p-value
Partial η2
Post-Hoc
Power
b
Immediate Memory Index
------List Learning
-0.05 (0.79)
0.21 (0.78)
1.54
0.23
0.09
0.26
Story Memory
0.18 (0.51)
0.19 (0.66)
0.09
0.77
0.01
0.07
Visuospatial Index
92.33 (18.36)
93.36 (18.40)
0.00
0.95
0.00
0.05
Figure Copy
-1.64 (2.11)
-1.50 (1.94)
0.02
0.88
0.00
0.05
Line Orientation a
0.29 (0.12)
0.29 (1.99)
0.55
0.47
0.04
0.14
Language Index
97.56 (10.17)
97.91 (14.41)
0.07
0.79
0.01
0.07
Semantic Fluency
-0.13 (1.06)
0.09 (1.42)
0.26
0.62
0.02
0.09
b
Picture Naming
------Attention Index
104.00 (11.81)
101.18 (12.34)
0.05
0.86
0.00
0.05
Digit Span
0.06 (1.14)
0.01(0.96)
0.04
0.84
0.00
0.05
Coding
0.43 (1.17)
0.00 (1.17)
0.59
0.45
0.04
0.14
Delayed Memory Index
99.78 (15.41)
99.73 (9.84)
0.03
0.86
0.00
0.05
List Recall
-0.15 (1.51)
0.15 (0.63)
0.47
0.50
0.03
0.11
a
List Recognition
0.22 (0.20)
0.26 (0.28)
0.00
0.98
0.00
0.05
Story Recall
0.29 (0.52)
0.31 (0.80)
0.01
0.94
0.00
0.05
Figure Recall
-1.17 (1.52)
0.24 (0.88)
0.43
0.52
0.03
0.11
Total Scale
98.11 (10.09)
98.27 (13.06)
0.07
0.80
0.00
0.05
a
Log Transformation applied to denoted variable.
b
Log Transformation applied to denoted variable and found to be unsuccessful. Variable precluded from subsequent analysis.

CHAPTER FOUR
DISCUSSION

Alcohol consumption, and certainly AUD, has been found to be significantly
related to subsequent cognitive impairments. Recovery from AUD has also been
associated with improvements in cognitive functioning. Our hypothesis that patients
receiving intensive outpatient treatment for an AUD would experience improvements in
cognitive function was partially supported by the current study results. Specifically, the
overall Total Scale on the RBANS improved by the end of treatment. Further, the
Language Index score also improved at follow-up, though this was not hypothesized.
Additional scores in the Index of Attention, and the subtests of Story Learning, Figure
Copy, Semantic Fluency, Digit Span, and Coding were no longer significant after
correction for multiple comparisons. However, given the small power and the utilization
of Bonferroni correction, these results may reflect a Type II error, or retaining the null
hypothesis when it should be rejected. This can be assessed by interpreting the effect
sizes of these variables, to evaluate if the improvement in scores is due to a statistical
relationship, or by chance. The effect sizes for the variables in question show that they
explain 21-52% of the variance in the analyses, suggesting that these values may be
significant (prior to correction) beyond the influence of chance. Additionally, a
retroactive power analysis suggested that there was insufficient power to detect true
changes in List Learning, Visuospatial index, Line orientation, Delayed Recall, List
Recall, List Recognition, Story Recall, and Figure Recall. Therefore, increasing power
may uncover increased improvements in cognitive functioning, across subtests and
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domains, after successful completion of outpatient treatment. Importantly, increasing the
sample size may provide additional power to detect if truly significant effect exists.
Improvements in cognitive functioning with abstinence have been found to be
largely variable depending on factors of length of abstinence and patient demographics
(e.g., age, SES, Veteran Affairs). Specifically, within the first two weeks of abstinence,
impairments remain within all cognitive domains (Fein, Bachman, Fisher, & Davenport,
1990), while at five weeks of abstinence, there are improvements in all domains with the
exception of verbal short-term memory (Mann, Gunther, Stetter, Ackeramann, 1999).
Within the first two months of detoxification, impairments within visuospatial processing
(Fein, Backman, Fisher, & Davenport, 1990) and verbal learning remained (Bell,
Vissicchio, & Weinstein, 2016). Furthermore, it has been noted that many individuals
exhibit at least partial recovery from their impairments (Bates, Buckman, & Nguyen,
2013). Notably, our results represent some variation compared to that of other studies, in
that by the end of approximately three weeks, our sample was showing improvements on
Language and overall cognitive functioning.
Our second hypothesis that baseline cognitive deficits would be more severe for
those who dropped out of treatment compared to treatment completers was not supported,
as the baseline cognitive differences were not significant after correcting for multiple
comparisons. However, the effect size for the Index of Attention, suggests there may be a
relationship beyond that of chance that was not detected due to insufficient power. This
effect size suggests that those who previously dropped out of treatment had poorer
performance on measures of Attention. When the sample was dichotomized into groups
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of impaired and intact cognitive functioning across all indices, results were similarly
insignificant after applying a Bonferroni correction.
Our final hypothesis that previous AUD treatment, indicative of previous relapse,
would be associated with poor cognitive functioning across treatment (beginning and end
of treatment) was not supported. Research has indicated that cognitive impairments will
reappear with relapse (Dominguez-Salas, Diaz-Batanero, Lozano-Rojas, & VerdejoGarcia, 2016; Duka, Townshend, Collier, & Stephens, 2003; Pitel et al., 2009), and may
even be worse than the patients’ own baseline level of performance (Pitel et al., 2009).
Notably, the sample utilized resulted in low power, based on post-hoc power analyses,
reducing our ability to determine if the engagement in previous treatment multiple times
reduces cognitive functioning beyond that of consistent alcohol use.
After correcting for multiple comparisons, findings suggest that patients engaged
in intensive outpatient treatment for an AUD will experience general improvements in
language and overall cognitive functioning within the three weeks of treatment or
sobriety, but may not experience significant changes in other specific domains of
cognition, such as memory or attention. This corroborates previous research by Fein,
Bachman, Fisher, and Davenport (1990) indicating that regardless of the intensity of
treatment, patients may require a greater period of sobriety to experience improvements
in cognitive functioning. Additionally, given the low power available, it is difficult to
determine if these results suggest that cognitive impairments are related to patient’s
tendency to prematurely drop-out of treatment. Finally, given the negative affect of
numerous alcohol relapses, it is important to evaluate cognitive functioning in patients
experiencing difficulties in their recovery. The results in this study were not suggestive of
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worse cognitive functioning when compared to other patients engaging in their first
treatment program. Again, given the reduced power utilized in this study, it is difficult to
determine if it is recurrent struggles with AUD, or an AUD in and of itself, that are
related to cognitive impairments.
It must be noted that there are some limitations to this study. The small number of
participants raises some questions with regard to power and significance, and prevents
true results from being extrapolated. Additionally, the assessment battery selected for this
study, while time efficient and appropriately brief to fit within the daily patient schedule
in treatment, exhibits a potential weakness for utilization in the AUD population.
Particularly, it does not contain a measure of executive functioning, which has been
found to be significantly influenced by significant alcohol use. Additionally, while the
RBANS has been found to have good validity and reliability, particularly as a screening
battery for dementia (Green, Sinclair, Rodgers, Birks, & Lincoln, 2013; Gold, Queern,
Iannone, & Buchanan, 1999; McKay, Casey, Wetheimer, & Fichtenberg 2006; Mooney
et al., 2007; Wilk et al., 2004), it may not be viable for the unique pattern of cognitive
performances exhibited within the AUD population. The AUD cognitive and
neurological profile are not suggestive of permanent neurological damage (e.g.,
Traumatic brain injury, stroke, or neurodegenerative disease), which the RBANS has
been found to have sufficient power to identify. Finally, this research fails to track
individuals following the completion of their treatment, and thus misses the potential for
subsequent recovery of their cognitive functioning in the long-term.
Overall, there were improvements in language and global cognitive functioning
for those who completed the intensive outpatient alcohol program. With increased sample
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size, additional cognitive domains and subtests (e.g., attention, story learning, figure
copy, semantic fluency, digit span, coding) may have displayed significant effects.
Nevertheless, the current study does suggest that intensive outpatient alcohol program
can help ameliorate at least some of the cognitive consequences associated with alcohol
use disorder.
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